Analyst Ratings for Edgewise Therapeutics (EWTX)
EWTX Rating Summary
EWTX Price Target Summary
- Highest: $66.00 (Raymond James)
- Lowest: $25.00 (Stifel)
- Average: $49.83
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$49.83 (+17.9%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 82%
Avg. $ Target:
$49.83 (+17.9%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/9/2026 | Oppenheimer | Mazahir Alimohamed | New Coverage | Outperform (N/A) |
51.00 (N/A) |
46.30 (42.25) |
-8.75% | Details |
| 9/25/2025 | Goldman Sachs » Updated 8/11/2026 |
Paul Choi | New Coverage | Neutral (N/A) |
36.00 (32.00) |
15.09 (42.25) |
179.99% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
